Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Biochem Pharmacol. 2021 Feb 3;189:114453. doi: 10.1016/j.bcp.2021.114453

Figure 8.

Figure 8.

In vivo therapeutic efficacy of IL-12/DOX co-loaded PMet-P(cdmPEG2K) micelleplexes. (A) Tumor growth plotted as relative tumor volume (mean ± SEM, n = 5); (B) Body weight changes of mice in different treatment groups (mean ± SD, n = 5); (C) Tumor weights after excision, plotted as relative tumor weight ratio. Tumor growth inhibition rate (IR, %) was calculated as: (1- (mean tumor weight of drug treated group/mean tumor weight of saline treated group)) * 100%. (D) Histological analyses of tumor tissues collected on day 18 using H&E staining.